Covered recipient · General Payments record
JULIE ANNE AUGUSTINE
Physician Assistants & Advanced Practice Nursing Providers Physician Assistant Medical
General Payments · PY2021–2023
$2,930.47
- Reported across 141 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2023 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $722.49 | 34 |
By paying entity
PY2023 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $239.29 | 20 |
| Axsome Therapeutics, Inc. | $145.54 | 2 |
| ITI, Inc. | $125.00 | 1 |
| Tris Pharma Inc | $39.51 | 2 |
| Lundbeck LLC | $38.94 | 2 |
| Takeda Pharmaceuticals U.S.A., Inc. | $37.71 | 2 |
| IDORSIA PHARMACEUTICALS US INC | $35.58 | 2 |
| Alkermes, Inc. | $21.94 | 1 |
| Grifols USA, LLC | $21.74 | 1 |
| Otsuka America Pharmaceutical, Inc. | $17.24 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2023 (34)
Sorted by paying entity, then date · as published by CMS
Program year 2023 20212022
Record-level detail is published for PY2023; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $11.95 | 04/25/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1002662503 | CMS |
| ABBVIE INC. | $7.29 | 05/01/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1002662517 | CMS |
| ABBVIE INC. | $9.27 | 05/12/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1002662529 | CMS |
| ABBVIE INC. | $8.39 | 06/01/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1002662541 | CMS |
| ABBVIE INC. | $8.86 | 06/07/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1002662553 | CMS |
| ABBVIE INC. | $3.82 | 06/14/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1002662565 | CMS |
| ABBVIE INC. | $10.38 | 06/15/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1002662575 | CMS |
| ABBVIE INC. | $11.20 | 07/17/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1002662585 | CMS |
| ABBVIE INC. | $10.74 | 08/01/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1002662597 | CMS |
| ABBVIE INC. | $13.48 | 08/14/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1002662609 | CMS |
| ABBVIE INC. | $12.62 | 08/22/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1002662621 | CMS |
| ABBVIE INC. | $19.08 | 08/30/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1002662633 | CMS |
| ABBVIE INC. | $18.13 | 09/15/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1002662647 | CMS |
| ABBVIE INC. | $6.37 | 09/25/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1002662659 | CMS |
| ABBVIE INC. | $8.94 | 10/03/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1002662671 | CMS |
| ABBVIE INC. | $12.50 | 10/10/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1002662683 | CMS |
| ABBVIE INC. | $21.22 | 10/16/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1002662695 | CMS |
| ABBVIE INC. | $9.86 | 12/04/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1002662705 | CMS |
| ABBVIE INC. | $13.23 | 12/12/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1002662717 | CMS |
| ABBVIE INC. | $21.96 | 12/19/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1002662729 | CMS |
| Alkermes, Inc. | $21.94 | 09/08/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1022773397 | CMS |
| Axsome Therapeutics, Inc. | $20.54 | 08/15/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1056295905 | CMS |
| Axsome Therapeutics, Inc. | $125.00 | 08/29/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1056295913 | CMS |
| Grifols USA, LLC | $21.74 | 07/21/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1011904517 | CMS |
| IDORSIA PHARMACEUTICALS US INC | $15.99 | 09/05/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1038260415 | CMS |
| IDORSIA PHARMACEUTICALS US INC | $19.59 | 11/07/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1038277013 | CMS |
| ITI, Inc. | $125.00 | 02/02/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1040778111 | CMS |
| Lundbeck LLC | $18.25 | 10/11/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1032429699 | CMS |
| Lundbeck LLC | $20.69 | 12/05/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1032429707 | CMS |
| Otsuka America Pharmaceutical, Inc. | $17.24 | 08/23/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1014970675 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $17.42 | 07/25/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1055703351 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $20.29 | 12/19/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1055703359 | CMS |
| Tris Pharma Inc | $13.70 | 08/02/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1059368587 | CMS |
| Tris Pharma Inc | $25.81 | 08/25/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1059368615 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023
- Source files
- Dataset page · Bulk file · PY2021 , PY2022 , PY2023
- Generated from
- OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.